Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Identification of effective screening strategies for cardiovascular disease prevention in a developing country: using cardiovascular risk-estimation and risk-reduction tools for policy recommendations.

Selvarajah S, Haniff J, Kaur G, Guat Hiong T, Bujang A, Chee Cheong K, Bots ML.

BMC Cardiovasc Disord. 2013 Feb 25;13:10. doi: 10.1186/1471-2261-13-10.

2.
3.

Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.

Boersma C, Gansevoort RT, Pechlivanoglou P, Visser ST, van Toly FF, de Jong-van den Berg LT, de Jong PE, Postma MJ; Prevention of Renal and Vascular End Stage Disease Study Group.

Clin Ther. 2010 Jun;32(6):1103-21. doi: 10.1016/j.clinthera.2010.06.013.

PMID:
20637965
4.

Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.

Greving JP, Buskens E, Koffijberg H, Algra A.

Circulation. 2008 Jun 3;117(22):2875-83. doi: 10.1161/CIRCULATIONAHA.107.735340. Epub 2008 May 27.

5.

Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.

Praditsitthikorn N, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, Ieumwananonthachai N, Tangcharoensathien V.

Pharmacoeconomics. 2011 Sep;29(9):781-806. doi: 10.2165/11586560-000000000-00000.

PMID:
21838332
6.

Allocating funds for cardiovascular disease prevention in light of the NCEP ATP III guidelines.

Caro J, Huybrechts KF, Klittich WS, Jackson JD, McGuire A; CORE Study Group.

Am J Manag Care. 2003 Jul;9(7):477-89.

7.

Developments in the screening for Chlamydia trachomatis: a review.

Kohl KS, Markowitz LE, Koumans EH.

Obstet Gynecol Clin North Am. 2003 Dec;30(4):637-58. Review.

PMID:
14719842
8.
11.
12.

The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial.

Diederichsen AC, Rasmussen LM, S√łgaard R, Lambrechtsen J, Steffensen FH, Frost L, Egstrup K, Urbonaviciene G, Busk M, Olsen MH, Mickley H, Hallas J, Lindholt JS.

Trials. 2015 Dec 5;16:554. doi: 10.1186/s13063-015-1082-6.

13.

Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.

Webb DR, Khunti K, Srinivasan B, Gray LJ, Taub N, Campbell S, Barnett J, Henson J, Hiles S, Farooqi A, Griffin SJ, Wareham NJ, Davies MJ.

Trials. 2010 Feb 19;11:16. doi: 10.1186/1745-6215-11-16.

14.
15.

Cost effectiveness of cardiovascular disease prevention strategies: a perspective on EU food based dietary guidelines.

Brunner E, Cohen D, Toon L.

Public Health Nutr. 2001 Apr;4(2B):711-5. Review.

PMID:
11683566
16.

Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.

Hoerger TJ, Harris R, Hicks KA, Donahue K, Sorensen S, Engelgau M.

Ann Intern Med. 2004 May 4;140(9):689-99.

PMID:
15126252
17.

Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals.

van Kempen BJ, Spronk S, Koller MT, Elias-Smale SE, Fleischmann KE, Ikram MA, Krestin GP, Hofman A, Witteman JC, Hunink MG.

J Am Coll Cardiol. 2011 Oct 11;58(16):1690-701. doi: 10.1016/j.jacc.2011.05.056.

18.

Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options.

Kypridemos C, Allen K, Hickey GL, Guzman-Castillo M, Bandosz P, Buchan I, Capewell S, O'Flaherty M.

BMJ. 2016 Jun 8;353:i2793. doi: 10.1136/bmj.i2793.

19.

Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.

Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD.

J Natl Cancer Inst. 2002 Oct 2;94(19):1469-83.

PMID:
12359856
20.

Cancer screening and health system resilience: keys to protecting and bolstering preventive services during a financial crisis.

Martin-Moreno JM, Anttila A, von Karsa L, Alfonso-Sanchez JL, Gorgojo L.

Eur J Cancer. 2012 Sep;48(14):2212-8. doi: 10.1016/j.ejca.2012.02.060. Epub 2012 Mar 15. Review.

PMID:
22424881

Supplemental Content

Support Center